The Office of the United States Trade Representative will hold a public hearing on September 22, 2026, to discuss the Section 301 investigation into Germany's pharmaceutical policies.
2026-09-22
The Office of the United States Trade Representative will hold a public hearing on September 22, 2026, to discuss the Section 301 investigation into Germany's pharmaceutical policies.